Global systemic antibiotics market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing with the healthy CAGR in the above-mentioned research forecast period. Emerging markets and advances in the pharmaceuticals sector are the factors responsible for the growth of this market.
The growth of systemic antibiotics market enhanced by the growing cases of infectious diseases and rise in research and development activities conducted by key players. In addition, increase patient awareness level and availability of the treatment options are considered a major factor for the growth of systemic antibiotics market. Nevertheless, product discontinuation coupled with side effects of the drugs are the factors that hinder the growth of this market.
Systemic antibiotics are the class of antibiotics that inhibits the growth of bacterial cell wall. A variety of systemic antibiotics can be given intravenously and subcutaneously and are widely used in the treatment of broad ranges of bacterial infectious diseases.
Global Systemic Antibiotics Market Scope and Market Size
Systemic antibiotics market is segmented on the basis of drug class, indication, end-users and distribution channel.
- Based on drug class, the systemic antibiotics market is segmented into beta lactam & beta lactamase inhibitors, quinolone, macrolide and others
- Indication section of systemic antibiotics market is segmented into urinary tract infection, intra-abdominal infections, blood stream infections, clostridium difficile infections and others
- On the basis of end-users, the global systemic antibiotics market is segmented into hospitals, homecare, specialty clinics and others
- On the basis of distribution channel, the global systemic antibiotics market has been bifurcated into hospital pharmacy, online pharmacy and retail pharmacy
Global Systemic Antibiotics Market Country Level Analysis
Systemic antibiotics market is analysed and market size information is provided by country, drug class, indication, end-users and distribution channel as referenced above.
The countries covered in the global systemic antibiotics market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, in the Asia-Pacific, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.
Competitive Landscape and Global Systemic Antibiotics Market Share Analysis
Systemic antibiotics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to systemic antibiotics market.
The major players covered in the global systemic antibiotics market are Bausch Health, Teva Pharmaceutical Industries Ltd, Dr. Reddy's Laboratories Ltd, Sun Pharmaceutical Industries Ltd, Amneal Pharmaceuticals PLC, Pfizer Inc, Mylan N.V., Novartis AG, Hikma Pharmaceuticals plc, Aurobindo Pharma, Allergan, and GlaxoSmithKline plc among others.